Heritage Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,120
Closed -$508K 201
2019
Q3
$508K Sell
5,120
-125
-2% -$11.9K 0.11% 132
2019
Q2
$485K Sell
5,245
-46
-0.9% -$4.37K 0.11% 132
2019
Q1
$499K Sell
5,291
-86
-2% -$7.52K 0.12% 129
2018
Q4
$345K Buy
5,377
+2,023
+60% +$149K 0.14% 94
2018
Q3
$300K Buy
3,354
+128
+4% +$11.3K 0.11% 105
2018
Q2
$256K Buy
3,226
+822
+34% +$68.3K 0.1% 108
2018
Q1
$214K Buy
2,404
+1,161
+93% +$111K 0.08% 112
2017
Q4
$130K Buy
1,243
+383
+45% +$43.2K 0.05% 130
2017
Q3
$125K Buy
860
+409
+91% +$55.7K 0.05% 134
2017
Q2
$59K Buy
451
+80
+22% +$9.8K 0.02% 173
2017
Q1
$46K Buy
+371
New +$44.4K 0.02% 195

Other funds holding CELG

Heritage Trust's CELG Position: Q4 2019 in Review

Heritage Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,120 shares — an estimated $508K sold.

Heritage Trust first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $508K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Heritage Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Heritage Trust sold 5,120 Celgene Corp shares in Q4 2019, an estimated $508K.
  • Heritage Trust first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • Heritage Trust's Celgene Corp position peaked at $508K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Heritage Trust's 13F filing for Q4 2019, filed 11 Feb 2020.